Codagenix Inc. announced favorable safety and immunogenicity data from a Phase I dose-escalation trial of the company’s single-dose intranasal COVI-VAC vaccine, and London-based pHOXBIO Ltd. reported results from a pivotal phase II/III study of the novel prophylactic nasal spray pHOXWELL.
Artificial Intelligence (AI) is at the forefront of modern technology and has begun to parallel in the world of biotechnology. Many biopharma companies are using AI to drive innovation, enhance their processes and explore new business models.
Swoop Introduces New Products to Redefine Physician Engagement Beyond Typical 1:1 National Provider Identifier Targeting and Revolutionize Heath Care Provider Marketing
Artificial Intelligence, Business, Digital, HCPs, Hospitals, Influencer Marketing, Marketing & Advertising, Physician Engagement, Real-world data, Return On Investment (ROI)Swoop, a leader in AI-generated digital audiences for healthcare, announced the release of its newest product offerings that uncover optimal healthcare provider (HCP) influencers for life sciences companies.
Two very exciting areas where Artificial Intelligence (AI) is having an impact on the life sciences landscape are patient stratification and synthetic control arms. Recent data and technology advances are starting to yield compelling results, according to Derek Baird, President North America of Sensyne Health and Commercial Director of SENSE.
Talkatoo, creators of the easy-to-use, efficient and platform-agnostic dictation software for animal health professionals, announced the closing of a new, oversubscribed round of funding led by Klick Ventures.
Real Chemistry, a global health innovation company, and Aktana, a leader in intelligent customer engagement for the global life sciences industry, announced a partnership that will transform commercial strategy, engagement and execution.
Health Technology Special Feature: Not Always Created Equal
Artificial Intelligence, August 2021, Data, Data Analysis, Ethnicity, Health Technology, Healthcare Communications Agencies, Issue Archives, Marketing & Advertising, Med Ad News, New England Journal of Medicine, Patients, Race, Special Features, TransparencyData and AI scientists must strive to eliminate bias from anything that touches patient care.
Better Outcomes from a Joint Approach to Medical Information and Pharmacovigilance: Improved Solutions for Local Operating Companies
Adverse Events, Artificial Intelligence, Business, Cloud, Digital Transformation, Health Technology, Healthcare Providers, Life Sciences, Medical Information, Pharma Companies, PharmacovigilanceCombining medical information (MI) and pharmacovigilance (PV) has been shown to drive an array of positive outcomes, including accelerating adverse event intake, improving healthcare professional and patient communications, intelligently connecting enterprise systems and importantly, driving better patient safety. New innovations in connected technologies are finally making it possible to combine elements of these functions in a thoughtful way. However, the change from legacy processes and mindset will be significant and driving employee adoption to see the benefit of these investments will require careful change management. IQVIA’s Annette Williams and Libbie McKenzie explore considerations for leaders looking to combine aspects of their MI and PV functions and how they can effectively roll out this shift to maximize the benefits to their organizations along with patients, providers, and other key stakeholders.
Toronto-based biotech Deep Genomics landed $180 million in the company’s oversubscribed Series C.
Hong Kong-based Insilico Medicine closed on a Series C financing round worth $255 million.